Thanks for your feedback. You raise many valid points. I would have liked to replace the impact by a more detailed analysis, but I don’t know how to go about doing this (measuring utility and adjusting for PPP is hard!). The impact math in the summary can be improved in many ways.
One important point which I seemed to have not explained well is that itraconazole is one of the most used antifungal drugs right now. It has been on the market for 30 years. It is already approved in most jurisdictions to treat various fungal infections. It is inexpensive, in part because there are now many generic manufacturers.
Hi Aaron,
Thanks for your feedback. You raise many valid points. I would have liked to replace the impact by a more detailed analysis, but I don’t know how to go about doing this (measuring utility and adjusting for PPP is hard!). The impact math in the summary can be improved in many ways.
One important point which I seemed to have not explained well is that itraconazole is one of the most used antifungal drugs right now. It has been on the market for 30 years. It is already approved in most jurisdictions to treat various fungal infections. It is inexpensive, in part because there are now many generic manufacturers.